NASDAQ:IMGNImmunoGen Earnings Date, Estimates & History

$5.07

-0.19 (-3.61 %)

(As of 05/26/2020 02:05 PM ET)

Add

Compare

Today's Range

$5.05

Now: $5.07▼

$5.28

50-Day Range

$3.39

MA: $4.01▼

$5.34

52-Week Range

$1.76

Now: $5.07▼

$7.07

Volume93,929 shs

Average Volume2.56 million shs

Market Capitalization$884.26 million

P/E RatioN/A

Dividend YieldN/A

Beta2.3

ImmunoGen (NASDAQ:IMGN) Earnings Information

ImmunoGen last announced its earnings results on May 1st, 2020. The biotechnology company reported ($0.17) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.15) by $0.02. The business earned $13.29 million during the quarter, compared to the consensus estimate of $14.53 million. ImmunoGen has generated ($0.70) earnings per share over the last year. ImmunoGen has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 7th, 2020 based off prior year's report dates.

ImmunoGen Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ImmunoGen (NASDAQ:IMGN) Earnings Estimates

2020 EPS Consensus Estimate: ($1.02)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2020	3	($0.33)	($0.16)	($0.25)
Q2 2020	3	($0.34)	($0.18)	($0.26)
Q3 2020	3	($0.30)	($0.22)	($0.26)
Q4 2020	3	($0.39)	($0.13)	($0.26)
Q1 2021	1	($0.07)	($0.07)	($0.07)
Q2 2021	1	($0.09)	($0.09)	($0.09)
Q3 2021	1	($0.09)	($0.09)	($0.09)

ImmunoGen (NASDAQ IMGN) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Reported EPS	GAAP EPS	Revenue Estimate	Actual Revenue	Conference Call
8/7/2020 (Estimated)
5/1/2020	3/31/2020	($0.15)	($0.17)	($0.17)	$14.53 million	$13.29 million	Transcript
2/14/2020	Q4 2019	($0.05)	$0.0324	$0.03	$29.24 million	$44.86 million	Transcript
11/1/2019	Q3 2019	($0.19)	($0.15)	($0.15)	$10.38 million	$13.30 million	Transcript
8/2/2019	6/30/2019	($0.32)	($0.29)	($0.29)	$10.33 million	$15.54 million	Listen
5/3/2019	3/31/2019	($0.31)	($0.30)	($0.30)	$10.59 million	$8.60 million	N/A
2/8/2019	12/31/2018	($0.33)	($0.2750)	($0.28)	$12.42 million	$13.79 million	Listen
11/2/2018	9/30/2018	($0.33)	($0.32)	($0.30)	$13.60 million	$10.90 million	N/A
7/27/2018	Q2 2018	($0.29)	($0.31)	($0.29)	$14.12 million	$9.29 million	N/A
5/4/2018	Q1 2018	($0.27)	($0.30)	($0.30)	$15.04 million	$19.80 million	N/A
2/9/2018	Q4 2017	($0.07)	($0.10)	($0.09)	$39.62 million	$39.40 million	Transcript

11/3/2017	Q3 2017	($0.19)	($0.61)	($0.13)	$26.09 million	$8.50 million	N/A
7/28/2017	Q2 2017	($0.1660)	($0.10)	($0.10)	$30.59 million	$39.02 million	N/A
5/5/2017	3/31/2017	($0.36)	($0.20)	($0.20)	$16.16 million	$28.70 million	N/A
2/17/2017	Q2 2017	($0.39)	($0.39)	($0.39)	$16.28 million	$13.85 million	Listen
10/28/2016	Q117	($0.38)	($0.51)	($0.41)	$21.12 million	$7.66 million	Listen
8/4/2016	Q416	($0.39)	($0.51)	($0.51)	$17.11 million	$7.41 million	Listen
4/29/2016	Q316	($0.31)	($0.37)	($0.37)	$23.02 million	$19.71 million	Listen
1/29/2016	Q216	($0.36)	($0.38)	($0.38)	$19.54 million	$18.03 million	Listen
10/27/2015	Q116	($0.35)	($0.39)	($0.39)	$15.84 million	$14.90 million	Listen
7/31/2015	Q415	($0.34)	($0.35)	($0.35)	$15.42 million	$12.61 million	Listen
4/24/2015	Q315	($0.25)	($0.25)	($0.25)	$20.95 million	$11.40 million	Listen
1/30/2015	Q215	($0.06)	$0.16	$0.16	$37.30 million	$48.30 million	Listen
10/24/2014	Q115	($0.14)	($0.26)	($0.26)	$21.80 million	$13.20 million	Listen
8/1/2014	Q414	($0.36)	($0.31)	($0.31)	$9.72 million	$5.74 million	N/A
4/25/2014	Q314	($0.27)	($0.44)	($0.14)	$13.28 million	$6.90 million	Transcript
1/31/2014	Q4 2013	($0.19)	$0.04	$0.04	$18.16 million	$30.10 million	Listen
10/25/2013	Q3 2013	($0.22)	($0.13)	($0.13)	$12.10 million	$17.20 million	Transcript
8/2/2013	Q2 2013	($0.30)	($0.26)	($0.26)	$3.44 million	$3.83 million	N/A
4/26/2013	Q1 2013	($0.14)	($0.02)	($0.02)	$11.94 million	$25.00 million	Transcript
1/25/2013	Q2 2013	($0.25)	($0.29)		$6.02 million	$2.60 million	N/A
10/26/2012	Q113	($0.25)	($0.30)		$4.10 million	$4.10 million	N/A
8/3/2012		($0.30)	($0.29)				N/A
4/27/2012		($0.26)	($0.24)				Transcript
1/27/2012		($0.22)	($0.17)				N/A
10/27/2011		($0.22)	($0.26)				N/A
8/3/2011		($0.24)	($0.23)				N/A
4/28/2011	Q1 2011	($0.23)	($0.22)	($0.22)			N/A
1/27/2011	Q4 2010	($0.22)	($0.21)	($0.21)			N/A
10/28/2010	Q3 2010	($0.23)	($0.19)	($0.19)			N/A
8/4/2010	Q2 2010	($0.24)	($0.21)	($0.21)			N/A
4/29/2010	Q1 2010	($0.23)	($0.21)	($0.21)			N/A
1/28/2010	Q4 2009	($0.21)	($0.23)	($0.23)			N/A
10/29/2009	Q3 2009	($0.20)	($0.22)	($0.22)			N/A
8/6/2009	Q2 2009	($0.17)	($0.21)	($0.21)			N/A
4/30/2009	Q1 2009	($0.10)	($0.09)	($0.09)			N/A
1/29/2009	Q4 2008	($0.15)	($0.14)	($0.14)			N/A
10/27/2008	Q3 2008	($0.21)	($0.19)	($0.19)			N/A
8/7/2008	Q2 2008	($0.25)	($0.27)	($0.27)			N/A
5/1/2008	Q1 2008	($0.21)	($0.30)	($0.30)			N/A
1/31/2008	Q4 2007	($0.11)	($0.15)	($0.15)			N/A

(Earnings results data provided by Zacks Investment Research)

This page was last updated on 5/26/2020 by MarketBeat.com Staff

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

NASDAQ:IMGNImmunoGen Earnings Date, Estimates & History

Adding

Adding

Adding ImmunoGen, Inc.

Earnings

ImmunoGen (NASDAQ:IMGN) Earnings Information

ImmunoGen Earnings Estimates and Actuals by Quarter

ImmunoGen (NASDAQ:IMGN) Earnings Estimates

ImmunoGen (NASDAQ IMGN) Earnings History by Quarter

Start Your Free Trial Today

Market Data and Calendars

Investing Education and Resources